What's in Gildasio Castello de Almeida Junior's pipeline?

Gildasio Castello de Almeida Junior has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Gildasio Castello de Almeida Junior's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gildasio-castello-de-almeida-junior.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Gildasio Castello de Almeida Junior — Portfolio Competitive Intelligence Brief

Gildasio Castello de Almeida Junior pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tranilast, and Tissucol	Tranilast, and Tissucol	phase 3	Anti-fibrotic agent (Tranilast); Fibrin sealant (Tissucol)	TGF-β pathway (Tranilast); Fibrin polymerization (Tissucol)	Dermatology, Wound Healing, Surgery

Therapeutic area mix

Dermatology, Wound Healing, Surgery · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Gildasio Castello de Almeida Junior:

Cite this brief

Drug Landscape (2026). Gildasio Castello de Almeida Junior — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gildasio-castello-de-almeida-junior. Accessed 2026-05-16.